Scripps 40th New Treatments in Chronic Liver Disease 2026

Description

Include: 14 videos Only no PDFs

Target Audience: hepatologists, gastroenterologists, internists, transplant specialists

New Treatments in Chronic Liver Disease will highlight the latest advancements in medications and therapies for liver care and transplantation. The program will offer an in-depth review of clinical trials and real-world data on oral treatments for chronic viral hepatitis B and C, non-alcoholic fatty liver disease, primary biliary cholangitis, primary sclerosing cholangitis, hepatocellular carcinoma, and complications of end-stage liver disease, including thrombocytopenia. This annual CME conference delivers a comprehensive yet targeted program designed to provide physicians with the latest updates and practical insights for managing liver diseases.

1. Cite new strategies for identifying and managing metabolic liver disease.
2. Review updated goals and guidelines for curing Delta Hepatitis, HBV and HCV.
3. Discuss potential new treatments for alcohol-related liver disease.
4. Summarize novel markers and therapies in PBC and PSC.
5. Evaluate liver masses and new therapeutic options for HCC.
6. Employ strategies for treating and managing ascites and hepatorenal syndrome.